Edition:
United Kingdom

People: Poxel SA (POXEL.PA)

POXEL.PA on Paris Stock Exchange

6.86EUR
4:35pm BST
Change (% chg)

€-0.18 (-2.56%)
Prev Close
€7.04
Open
€7.01
Day's High
€7.09
Day's Low
€6.83
Volume
27,456
Avg. Vol
138,159
52-wk High
€9.18
52-wk Low
€4.92

Bozec, Sophie 

Dr. Sophie Bozec is Senior Vice President Pharmacology (Diabetes) at Poxel SA. She graduated from Paris VII with a Doctorate degree in Biology. She has 16 years of experience in the field. Sophie Bozec joined Merck KGaA in 1998 where she managed a drug discovery team in a pharmacology department. Dr. Bozec has acquired a strong experience for managing research projects from target identification to preclinical development candidates. She has developed her knowledge in models (in vivo and in vitro) used in research programs for identifying preclinical development candidates in the diabetes field. She acquired a solid expertise in metabolic diseases particularly in the diabetes field. This experience in pharmacology led Dr. Bozec to support a clinical development compound for all preclinical pharmacology aspects.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --